Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2026
The evolving landscape of CAR T cell therapy in children and young adults with B cell acute lymphoblastic leukemia.
Journal: Molecular therapy. Oncology
Published: March 20, 2026
Bringing in vivo CAR to the clinic: Promise, pitfalls, and questions to ask.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 11, 2026
Impact of blinatumomab and inotuzumab exposure on apheresis composition for CAR T in patients with B-cell acute lymphoblastic leukemia.
Journal: Cytotherapy
Published: January 09, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing with Engineered Immune Effector Cells.
Journal: Transplantation and cellular therapy
Published: January 05, 2026
Endothelial activation and stress index score as a predictor of transplant-associated thrombotic microangiopathy in patients with sickle cell disease.
Journal: British journal of haematology
Published: November 21, 2025
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.
Journal: Pediatric blood & cancer
Published: July 24, 2025
Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology Group.
Journal: Pediatric blood & cancer
Published: May 27, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
Journal: Cytotherapy
Published: May 06, 2025
Last Updated: 09/26/2026